Nurofen Express Maximum Strength 400mg Tablets
*Company:
Reckitt Benckiser Ireland LimitedStatus:
UpdatedLegal Category:
Supply through pharmacy onlyActive Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 10 April 2024
File name
IE PIL Nurofen Rapid Relief 400mg Clean CRN00DDJT PRAC 7.pdf
Reasons for updating
- Change to section 2 - pregnancy, breast feeding and fertility
Updated on 10 April 2024
File name
IE SPC Nurofen Express 400mg SPC Clean CRN00DDJT PRAC 7.pdf
Reasons for updating
- Change to section 4.6 - Pregnancy and lactation
Legal category:Supply through pharmacy only
Updated on 23 October 2021
File name
Nurofen Express 400mg Tabs PIL Apr21.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
Updated on 23 October 2021
File name
Nurofen Express 400mg Tabs SmPC Apr21.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
Legal category:Supply through pharmacy only
Updated on 02 April 2020
File name
SPC Nurofen Express Max Strength 400mg Mar 20.pdf
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category:Supply through pharmacy only
Updated on 02 April 2020
File name
Express 400mg Tablets PIL.pdf
Reasons for updating
- Change to section 4 - possible side effects
Updated on 15 January 2020
File name
Nurofen Express Maximum Strength 400mg Tablets.pdf
Reasons for updating
- Change to section 6 - manufacturer
Updated on 02 August 2018
File name
Nurofen Express Maximum Strength 400mg Tablets SPC 12.06.18.pdf
Reasons for updating
- Change to section 6.5 - Nature and contents of container
Legal category:Supply through pharmacy only
Updated on 15 December 2017
Reasons for updating
- New SPC for new product
Legal category:Supply through pharmacy only
Updated on 15 December 2017
Reasons for updating
- Change to section 9 - Date of first authorisation/renewal of the authorisation
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Date of revision of text: September 2017
Updated on 13 December 2017
File name
PIL_15039_260.pdf
Reasons for updating
- New PIL for new product
Updated on 13 December 2017
Reasons for updating
- Change to section 6 - what the product looks like and pack contents
Updated on 17 August 2017
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 4 - possible side effects
Updated on 16 August 2017
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Section 4.4 and 4.8 updated with Chicken pox warning.
Section 10 date of revision of text updated.
Updated on 10 October 2014
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Updated on 07 October 2014
Reasons for updating
- Change to warnings or special precautions for use
- Change to dosage and administration
Updated on 10 April 2014
Reasons for updating
- Change to warnings or special precautions for use
- Change of contraindications
Updated on 12 February 2014
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.4 - Special warnings and precautions for use
- Change due to harmonisation of SPC
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Section 4.4 cardiovascular & cerebrovascular effects reworded
Updated on 16 March 2012
Reasons for updating
- Change to section 6.1 - List of excipients
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
*(containing: Shellac, iron oxide red (E172),propylene glycol (E1520), ammonium hydroxide (E257) , and simethicone)
Updated on 14 March 2012
Reasons for updating
- Change of inactive ingredient
Updated on 06 July 2011
Reasons for updating
- New PIL for new product
Updated on 22 June 2011
Reasons for updating
- New SPC for new product
Legal category:Supply through pharmacy only